1137071

Progenics Pharmaceuticals, Inc. — FEI 3013080312

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 26, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Sponsor, Contract Research Organization